S. Miyakis, M. Lockshin, T. Atsumi, D. Branch, and R. Brey, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), Journal of Thrombosis and Haemostasis, vol.75, issue.2, pp.295-306, 2006.
DOI : 10.1093/ajcp/103.1.103

B. De-laat, V. Pengo, I. Pabinger, J. Musial, and A. Voskuyl, The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study, Journal of Thrombosis and Haemostasis, vol.138, issue.11, pp.1767-1773, 2009.
DOI : 10.1111/j.1538-7836.2008.02862.x

G. Iverson, S. Reddel, E. Victoria, K. Cockerill, and Y. Wang, Use of Single Point Mutations in Domain I of ??2-Glycoprotein I to Determine Fine Antigenic Specificity of Antiphospholipid Autoantibodies, The Journal of Immunology, vol.169, issue.12, pp.7097-7103, 2002.
DOI : 10.4049/jimmunol.169.12.7097

Y. Ioannou, C. Pericleous, I. Giles, D. Latchman, and D. Isenberg, Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human ??2-glycoprotein I: Mutation studies including residues R39 to R43, Arthritis & Rheumatism, vol.52, issue.1, pp.280-290, 2007.
DOI : 10.1042/bst0240274

B. De-laat, R. Derksen, R. Urbanus, and P. De-groot, IgG antibodies that recognize epitope Gly40-Arg43 in domain I of ??2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis, Blood, vol.105, issue.4, pp.1540-1545, 2005.
DOI : 10.1182/blood-2004-09-3387

B. De-laat, R. Derksen, M. Van-lummel, M. Pennings, and P. De-groot, Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change, Blood, vol.107, issue.5, pp.1916-1924, 2006.
DOI : 10.1182/blood-2005-05-1943

C. Agar, G. Van-os, M. Morgelin, R. Sprenger, and J. Marquart, ??2-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome, Blood, vol.116, issue.8, pp.1336-1343, 2010.
DOI : 10.1182/blood-2009-12-260976

M. Hammel, M. Kriechbaum, A. Gries, G. Kostner, and P. Laggner, Solution Structure of Human and Bovine ??2-Glycoprotein I Revealed by Small-angle X-ray Scattering, Journal of Molecular Biology, vol.321, issue.1, pp.85-97, 2002.
DOI : 10.1016/S0022-2836(02)00621-6

B. Bouma, P. De-groot, J. Van-den-elsen, R. Ravelli, and A. Schouten, Adhesion mechanism of human beta 2-glycoprotein I to phospholipids based on its crystal structure, The EMBO Journal, vol.18, issue.19, pp.5166-5174, 1999.
DOI : 10.1093/emboj/18.19.5166

R. Schwarzenbacher, K. Zeth, K. Diederichs, A. Gries, and G. Kostner, Crystal structure of human ??2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome, The EMBO Journal, vol.18, issue.22, pp.6228-6239, 1999.
DOI : 10.1093/emboj/18.22.6228

A. Tincani, M. Filippini, M. Scarsi, M. Galli, and P. Meroni, European attempts for the standardisation of the antiphospholipid antibodies, Lupus, vol.157, issue.10, pp.913-919, 2009.
DOI : 10.1177/0961203308097569

K. Devreese, Standardization of antiphospholipid antibody assays. Where do we stand?, Lupus, vol.68, issue.2, pp.718-721, 2012.
DOI : 10.1016/j.cca.2011.09.048

R. Willis, E. Harris, and S. Pierangeli, Current International Initiatives in Antiphospholipid Antibody Testing, Seminars in Thrombosis and Hemostasis, vol.38, issue.04, pp.360-374, 2012.
DOI : 10.1055/s-0032-1313564

I. Dienava-verdoold, M. Boon-spijker, P. De-groot, H. Brinkman, and J. Voorberg, Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activity, Journal of Thrombosis and Haemostasis, vol.99, issue.4, pp.738-747, 2011.
DOI : 10.1182/blood.V99.8.2828

C. Agar, P. De-groot, M. Morgelin, S. Monk, and G. Van-os, ??2-Glycoprotein I: a novel component of innate immunity, Blood, vol.117, issue.25, pp.6939-6947, 2011.
DOI : 10.1182/blood-2010-12-325951

S. Pierangeli, E. Favaloro, G. Lakos, P. Meroni, and A. Tincani, Standards and reference materials for the anticardiolipin and anti-??2glycoprotein I assays: A report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies, Clinica Chimica Acta, vol.413, issue.1-2, pp.358-360, 2012.
DOI : 10.1016/j.cca.2011.09.048

G. Iverson, E. Matsuura, E. Victoria, K. Cockerill, and M. Linnik, The Orientation of ??2GPI on the Plate is Important for the Binding of Anti-??2GPI Autoantibodies by ELISA, Journal of Autoimmunity, vol.18, issue.4, pp.289-297, 2002.
DOI : 10.1006/jaut.2002.0590

A. Tsutsumi, K. Ichikawa, E. Matsuura, K. Sawada, and T. Koike, Heterogeneous behavior of anti-beta2-glycoprotein I antibodies on various commercially available enzyme immunoassay plates coated with beta2- glycoprotein I, J Rheumatol, vol.27, pp.391-396, 2000.

G. Reber, I. Schousboe, A. Tincani, M. Sanmarco, and T. Kveder, Interlaboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group, Thromb Haemost, vol.88, pp.66-73, 2002.

R. Urbanus and P. De-groot, Antiphospholipid antibodies ??? We are not quite there yet, Blood Reviews, vol.25, issue.2, pp.97-106, 2011.
DOI : 10.1016/j.blre.2010.12.001